SEARCH OUR PRODUCT CATALOG

AGAP1-ERBB4 Fusion FISH Probe

The AGAP1-ERBB4 Fusion FISH Probe is used to confirm a fusion of the AGAP1 and ERBB4 genes. The fusion of the AGAP1 and ERBB4 genes has been associated with Pancreatic Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
AGAP1-ERBB4-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
AGAP1-ERBB4-20-RERE 20 (40 μL) 200 μL
AGAP1-ERBB4-20-REOR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-REGO 20 (40 μL) 200 μL
AGAP1-ERBB4-20-REGR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-REAQ 20 (40 μL) 200 μL
AGAP1-ERBB4-20-ORRE 20 (40 μL) 200 μL
AGAP1-ERBB4-20-OROR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-ORGO 20 (40 μL) 200 μL
AGAP1-ERBB4-20-ORAQ 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GORE 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GOOR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GOGO 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GOGR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GOAQ 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GRRE 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GROR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GRGO 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GRGR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-GRAQ 20 (40 μL) 200 μL
AGAP1-ERBB4-20-AQRE 20 (40 μL) 200 μL
AGAP1-ERBB4-20-AQOR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-AQGO 20 (40 μL) 200 μL
AGAP1-ERBB4-20-AQGR 20 (40 μL) 200 μL
AGAP1-ERBB4-20-AQAQ 20 (40 μL) 200 μL

ERBB4 Gene Summary

This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]

Gene Name: Erb-b2 Receptor Tyrosine Kinase 4

Chromosome: CHR2: 212240441 -213403352

Locus: 2q34

AGAP1 Gene Summary

This gene encodes a member of an ADP-ribosylation factor GTPase-activating protein family involved in membrane trafficking and cytoskeleton dynamics. This gene functions as a direct regulator of the adaptor-related protein complex 3 on endosomes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

Gene Name: ArfGAP With GTPase Domain, Ankyrin Repeat And PH Domain 1

Chromosome: CHR2: 236402735 -237034120

Locus: 2q37.2

Gene Diseases

The AGAP1 ERBB4 Fusion has been associated with the following diseases:

Disease Name
Pancreatic Adenocarcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma

Chromophobe renal cell carcinoma (ChRCC) and renal oncocytoma (RO) are two tumors that are difficult to distinguish from one another. It is important to distinguish them because ChRCC is a malignant tumor whereas RO is a benign tumor. Deletion of the RB1 and ERBB4 genes are indicative of ChRCC because these are tumor-suppressant genes. FISH analysis was used to identify these deletions. Our dual color probes were used that targeted RB1-Orange (MAC clone RP11-893E5) and 13q11-Green (RP11-408E5). A green ERBB4 probe was also used.

The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma

Renal oncocytoma (RO) is a benign epithelial neoplasm that makes up about 5 to 9% of all renal cell tumors. RO can be difficult to distinguish from a closely related but malignant counterpart, chromophobe renal cell carcinoma (ChrCC). This study used both IHC and FISH to detect the presence of RB1 and ERBB4, two genes that have been found deleted in ChrCC but not RO. A total of 28 ChrCCs and 25 RO cases were tested. Empire Genomics’ RB1 and ERBB4 FISH probes were used to detect deletions in these genes.